| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.02 | 0.7 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.043 | 0.4 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.064 | 0.3 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.056 | 0.3 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.065 | 0.3 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.061 | 0.2 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.063 | 0.2 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.076 | 0.2 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.077 | 0.2 |